ANN HANHAM
CIK 1286338 · last filed 2025-06-30
ANN HANHAM is a corporate insider who has filed 44 SEC Form 4 insider transactions across 3 companies since 2011. The most recent filing, for SCYX, was dated Jun 30, 2025. Across all open-market trades the lifetime net is −$5.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $294.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$294.5K
3
44
-$5.33M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SCYX | Director | 69,622 | $4.23 | $294.5K | $35.4K | 19 | 2025-06-30 |
| HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted | Director | 7,304 | $0.48 | $3.5K | $0 | 8 | 2022-09-15 |
| ENDOCYTE INC (ECYT) Delisted | Director | 62,096 | — | — | -$5.37M | 17 | 2017-05-05 |
Recent Filings
44 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-30 | SCYX | Grant (A) | +23,000 | $0 | EDGAR |
| 2024-06-21 | SCYX | Grant (A) | +23,000 | $0 | EDGAR |
| 2023-06-23 | SCYX | Grant (A) | +10,000 | $0 | EDGAR |
| 2023-06-20 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2022-09-15 | HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-22 | SCYX | Grant (A) | +10,000 | $0 | EDGAR |
| 2021-08-19 | HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-21 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2021-03-31 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2020-12-23 | SCYX | Mixed | +3,200 | $20.0K | EDGAR |